Professional Documents
Culture Documents
1 s2.0 S0378517314008552 Main
1 s2.0 S0378517314008552 Main
Pharmaceutical nanotechnology
A R T I C L E I N F O A B S T R A C T
Article history: In this paper the stability of the arsenic sulfide (As4S4) nanosuspension prepared by wet milling in a
Received 15 September 2014 circulation mill in the environment of copolymer Poloxamer 407 was studied. The obtained As4S4
Received in revised form 14 November 2014 particles in nanosuspension were of 100 nm in size. The influence of temperature and UV irradiation on
Accepted 17 November 2014
the changes in physical and/or chemical properties was followed. Long-term stability was observed via
Available online 18 November 2014
particle size distribution and zeta potential measurements. Influence of UV irradiation was studied via
UV–vis spectroscopy (UV–vis), photoluminicsence (PL) technique and Fourier transform infrared
Keywords:
spectroscopy (FTIR) measurements. The best stability of the nanosuspension (24 weeks) was achieved
Nanosuspension
Stability
when stored at 4 C and in the dark.
Nanomilling ã 2014 Elsevier B.V. All rights reserved.
Arsenic sulfide
Particle size
http://dx.doi.org/10.1016/j.ijpharm.2014.11.043
0378-5173/ ã 2014 Elsevier B.V. All rights reserved.
188 áková et al. / International Journal of Pharmaceutics 478 (2015) 187–192
Z. Bujn
Fig. 5. (a) UV–vis absorption spectra, (b) particle size distribution, (c) PL spectra, and (d) FTIR spectra of As4S4 nanosuspension after UV irradiation at various times (up to 6 h).
áková et al. / International Journal of Pharmaceutics 478 (2015) 187–192
Z. Bujn 191
Wang, Y., Zheng, Y., Zhang, L., Wang, Q., Zhang, D., 2013. Stability of nanosuspensions Ye, H.-Q., Gan, L., Yang, X.-L., Xu, H.-B., 2006. Membrane-associated cytotoxicity
in drug delivery. J. Control. Release 172, 1126–1141. induced by realgar in promyelocytic leukemia HL-60 cells. J. Ethnopharmacol.
Wu, J.-Z., Ho, P.C., 2006. Evaluation of the in vitro activity and in vivo 103, 366–371.
bioavailability of realgar nanoparticles prepared by cryo-grinding. Eur. J. Yuan, L., Wang, C., Liu, W., Gou, B., Zhang, T., 2013. Realgar induces differentiation
Pharm. Sci. 29, 35–44. through ROS-dependent mitochondrial pathway in HL-60 cells. J. Chin. Pharm.
Wu, J., Shao, Y., Liu, J., Chen, G., Ho, P.C., 2011. The medical use of realgar (As4S4) and its Sci. 22, 184–189.
recent development as an anticancer agent. J. Ethnopharmacol. 135, 595–602.